<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Prices of Medicines</title>
    <link>https://www.taxtmi.com/news?id=4140</link>
    <description>Under the DPCO, 1995 the NPPA fixes or revises prices of formulations containing the 74 scheduled bulk drugs using the para 7 formula (Material, Conversion, Packing costs, allowable post manufacturing expenses and taxes) to determine MRP; scheduled formulations cannot be sold above NPPA notified prices. For non scheduled drugs manufacturers set prices but NPPA monitors price movements and may act under paragraph 10(b) where annual increases exceed 10 percent.</description>
    <language>en-us</language>
    <pubDate>Fri, 30 Nov 2012 14:44:12 +0530</pubDate>
    <lastBuildDate>Fri, 30 Nov 2012 14:44:12 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=306876" rel="self" type="application/rss+xml"/>
    <item>
      <title>Prices of Medicines</title>
      <link>https://www.taxtmi.com/news?id=4140</link>
      <description>Under the DPCO, 1995 the NPPA fixes or revises prices of formulations containing the 74 scheduled bulk drugs using the para 7 formula (Material, Conversion, Packing costs, allowable post manufacturing expenses and taxes) to determine MRP; scheduled formulations cannot be sold above NPPA notified prices. For non scheduled drugs manufacturers set prices but NPPA monitors price movements and may act under paragraph 10(b) where annual increases exceed 10 percent.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Fri, 30 Nov 2012 14:44:12 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=4140</guid>
    </item>
  </channel>
</rss>